Knockout Tested Mouse Monoclonal CREB antibody. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human, Mouse, Rat, African green monkey samples. Cited in 32 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CREB1.
View Alternative Names
Cyclic AMP-responsive element-binding protein 1, CREB-1, cAMP-responsive element-binding protein 1, CREB1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB antibody [LB9] (AB178322)
Immunohistochemical analysis of deparaffinized Human tonsil tissue labeling CREB with ab178322 at 1/100 dilution followed by DAB staining.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CREB antibody [LB9] (AB178322)
Immunofluorescent analysis of untreated HeLa cells (formalin-fixed, 0.1% Triton X-100 permeabilized) labeling CREB with ab178322 at 1/400 dilution (green) followed with DyLight 488 goat anti-mouse IgG secondary antibody at 1/400 dilution. Nuclei (blue) were stained with Hoechst 33342 dye.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CREB antibody [LB9] (AB178322)
Immunofluorescent analysis of untreated HeLa cells (formalin-fixed, 0.1% Triton X-100 permeabilized) labeling CREB with ab178322 at 1/500 dilution (green) followed with DyLight 488 goat anti-mouse IgG secondary antibody at 1/400 dilution. Nuclei (blue) were stained with Hoechst 33342 dye.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CREB antibody [LB9] (AB178322)
Immunohistochemical analysis of deparaffinized Human bladder cancer (left) and rectal cancer (right) tissues labeling CREB with ab178322 at 1/200 dilution followed by DAB staining.
- IP
Supplier Data
Immunoprecipitation - Anti-CREB antibody [LB9] (AB178322)
Immunoprecipitation analysis of CREB was performed on untreated 293T cells. The antigen : antbody complex was formed by binding 500μg whole cell lysate with 2μg ab178322 and captured on 50μl Protein A/G Plus Agarose.
Lane 1 : 293T lysate
Lane 2 : IP of 293T lysate
WB detection used ab178322 at 1/1000 followed with a goat anti-mouse-HRP secondary antibody at 1/20,000.
All lanes:
Immunoprecipitation - Anti-CREB antibody [LB9] (ab178322)
Predicted band size: 36 kDa
true
- WB
Lab
Western blot - Anti-CREB antibody [LB9] (AB178322)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : CREB knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : A431 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab178322 observed at 44 kDa. Red - loading control, ab18058, observed at 124 kDa.
ab178322 was shown to recognize CREB when CREB knockout samples were used, along with additional cross-reactive bands. Wild-type and CREB knockout samples were subjected to SDS-PAGE. ab178322 and ab18058 (loading control to Vinculin) were diluted at 1/250 and 1/10,000 dilution respectively and incubated overnight at 4C. Blots were developed with IRDye® 800CW Goat anti-Rabbit IgG (H + L) and IRDye® 680 Goat anti-Mouse IgG (H + L) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CREB antibody [LB9] (ab178322)
Predicted band size: 36 kDa
false
- WB
Lab
Western blot - Anti-CREB antibody [LB9] (AB178322)
Western blot : Anti-CREB1 antibody [LB9] (ab178322) staining at 1/500 dilution, shown in green; Rabbit anti-ACTN4 [EPR2533(2)] (ab108198) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab178322 was shown to bind specifically to CREB1. A band was observed at 40 kDa in wild-type A549 cell lysates with no signal observed at this size in CREB1 knockout cell line. To generate this image, wild-type and CREB1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CREB antibody [LB9] (ab178322) at 1/500 dilution
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
CREB1 knockout HCT 116 cell lysate at 20 µg
Lane 3:
Wild-type A549 ab288558 cell lysate at 20 µg
Lane 4:
CREB1 knockout A549 <a href='/en-us/products/cell-lines/human-creb1-knockout-a549-cell-line-ab286720'>ab286720</a> cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution
Predicted band size: 36 kDa
Observed band size: 40 kDa
false
- WB
Supplier Data
Western blot - Anti-CREB antibody [LB9] (AB178322)
All lanes:
Western blot - Anti-CREB antibody [LB9] (ab178322) at 1/500 dilution
Lane 1:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 30 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 30 µg
Lane 3:
K-562 (Human chronic myelogenous leukemia lymphoblast cell line ) whole cell lysate at 30 µg
Lane 4:
Hep G2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 30 µg
Lane 5:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 30 µg
Lane 6:
C2C12 whole cell lysate at 30 µg
Lane 7:
U-2 OS (Human bone osteosarcoma epithelial cell line) whole cell lysate at 30 µg
Lane 8:
A549 (Human lung carcinoma cell line) whole cell lysate at 30 µg
Lane 9:
MDA-MB-231 (Human breast adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 10:
T98G whole cell lysate at 30 µg
Predicted band size: 36 kDa
Observed band size: 43 kDa
false
- WB
Supplier Data
Western blot - Anti-CREB antibody [LB9] (AB178322)
All lanes:
Western blot - Anti-CREB antibody [LB9] (ab178322) at 1/500 dilution
Lane 1:
HeLa whole cell lysate at 25 µg
Lane 2:
293T whole cell lysate at 25 µg
Lane 3:
A431 whole cell lysate at 25 µg
Lane 4:
A549 whole cell lysate at 25 µg
Lane 5:
MEF whole cell lysate at 25 µg
Lane 6:
MCF7 whole cell lysate at 25 µg
Lane 7:
U2OS whole cell lysate at 25 µg
Lane 8:
K562 whole cell lysate at 25 µg
Lane 9:
COS7 whole cell lysate at 25 µg
Lane 10:
3T3L1 whole cell lysate at 25 µg
Lane 11:
C2C12 whole cell lysate at 25 µg
Lane 12:
NRK whole cell lysate at 25 µg
Secondary
All lanes:
goat anti-mouse-HRP at 1/20000 dilution
Predicted band size: 36 kDa
true
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CREB contributes significantly to cellular processes such as proliferation differentiation and survival through transcriptional regulation. CREB does not function alone; it frequently associates with other proteins forming complexes to exert its regulatory roles. Additionally CREB influences the development of memory and learning in neurons highlighting its extensive involvement in neurophysiological processes.
Pathways
CREB plays a substantial role in the cAMP signaling pathway as well as the mitogen-activated protein kinase (MAPK) pathway. Through its interaction with kinases and other signaling proteins CREB influences numerous downstream targets affecting cellular responses to external stimuli. Notably protein kinase A (PKA) activates CREB by phosphorylation facilitating its role in various signal transduction pathways and linking it to downstream transcriptional events.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (32)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:22679 PubMed40596516
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of nanomedicine 19:13525-13546 PubMed39720214
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 28:358 PubMed38881713
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109125 PubMed38420594
2024
Applications
Unspecified application
Species
Unspecified reactive species
Immunity, inflammation and disease 12:e1176 PubMed38411331
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:1030 PubMed38310104
2024
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37:e23288 PubMed37997502
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107536 PubMed37636073
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:104946 PubMed37348559
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1114596 PubMed36969204
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com